Medical Devices

Point-of-care Glucose Testing Market By End-user (home care settings, hospitals & clinics, professional diagnostic centers, and others), By Testing site (alternate site testing and fingertip), By Product (meters, lancets & lancing devices, and strips) And By Region: - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2024-2032

According to the report published by Market Research Store, the global Point-of-care glucose testing market size was valued at USD 3,351.29 Million in 2023 and is predicted to reach USD 4,804.04 Million by the end of 2032. The market is expected to grow with a CAGR of 4.05% during the forecast period. The report analyzes the global Point-of-care Glucose testing markets growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arisin

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 207
  • Published: Mar-2024
  • Single User:US $3950.00
Medical Devices

Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market (By Type: Niraparib (Zejula), Olaparib (Lynparza), Rucaparib (Rubraca), Talazoparib (Talzenna); By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investme

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 60
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

Enzyme Poly ADP Ribose Polymerase Inhibitor Market (By Type: Niraparib (Zejula), Olaparib (Lynparza), Rucaparib (Rubraca), Talazoparib (Talzenna); By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global Enzyme Poly ADP Ribose Polymerase Inhibitor was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global Enzyme Poly ADP Ribose Polymerase Inhibitor market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top mark

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 68
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

H2 Antagonist Market (By Type: Tablet, Chewable, Injectable; By Application: Hospital, Laboratory, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global H2 Antagonist was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global H2 Antagonist market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market players in RD and adoption of AI and IoT technologies has

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 64
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

Incretin Mimetics Market (By Type: Exenatide, Liraglutide, Lixisenatide, Albiglutide, Others; By Application: Solid Tumors, Blood-related Tumors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global Incretin Mimetics was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global Incretin Mimetics market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market players in RD and adoption of AI and IoT technolo

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 67
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

GLP-1 Receptor Agonists Market (By Type: Exenatide, Liraglutide, Lixisenatide, Albiglutide, Others; By Application: Solid Tumors, Blood-related Tumors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global GLP-1 Receptor Agonists was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global GLP-1 Receptor Agonists market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market players in RD and adoption of AI and

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 62
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

Glucagon-like Peptide-1 Receptor Agonist Market (By Type: Exenatide, Liraglutide, Lixisenatide, Albiglutide, Others; By Application: Solid Tumors, Blood-related Tumors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global Glucagon-like Peptide-1 Receptor Agonist was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global Glucagon-like Peptide-1 Receptor Agonist market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market pla

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 63
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

GLP-1R Agonist Market (By Type: Exenatide, Liraglutide, Lixisenatide, Albiglutide, Others; By Application: Solid Tumors, Blood-related Tumors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global GLP-1R Agonist was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global GLP-1R Agonist market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market players in RD and adoption of AI and IoT technologies h

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 63
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

PD-1 and PD-L1 Immunotherapy Market (By Type: PD-1 inhibitor, PD-L1 inhibitor; By Application: Solid Tumors, Blood-related Tumors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global PD-1 and PD-L1 Immunotherapy was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global PD-1 and PD-L1 Immunotherapy market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market players in RD and adoption

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 69
  • Published: Mar-2022
  • Single User:US $3250.00
Medical Devices

PD-1 and PD-L1 Antibody Market (By Type: PD-1 inhibitor, PD-L1 inhibitor; By Application: Solid Tumors, Blood-related Tumors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2028

Report Description: The global PD-1 and PD-L1 Antibody was valued at USD (xxx) in 2022 and it is estimated to surpass around USD (xxx) by 2028 with a registered CAGR of [CAGR] % during the forecast period 2022 to 2028. Growth Factors According to Market research store, the global PD-1 and PD-L1 Antibody market, growing number of demand and the rising globalization of business has led to a rapid growth in business. The growing investment by top market players in RD and adoption of AI and

  • Category: Medical Devices
  • Publisher: MRS Research
  • Pages: 61
  • Published: Mar-2022
  • Single User:US $3250.00
-->